363 related articles for article (PubMed ID: 32033229)
41. Chemistry, Pharmacology, and Toxicology of Monoisoamyl Dimercaptosuccinic Acid: A Chelating Agent for Chronic Metal Poisoning.
Flora SJS; Jain K; Panghal A; Patwa J
Chem Res Toxicol; 2022 Oct; 35(10):1701-1719. PubMed ID: 35972774
[TBL] [Abstract][Full Text] [Related]
42. Lack of effectiveness of D-penicillamine in experimental arsenic poisoning.
Kreppel H; Reichl FX; Forth W; Fichtl B
Vet Hum Toxicol; 1989 Feb; 31(1):1-5. PubMed ID: 2540587
[TBL] [Abstract][Full Text] [Related]
43. Recovery from severe arsenic-induced peripheral neuropathy with 2,3-dimercapto-1-propanesulphonic acid.
Wax PM; Thornton CA
J Toxicol Clin Toxicol; 2000; 38(7):777-80. PubMed ID: 11192465
[TBL] [Abstract][Full Text] [Related]
44. Antidotal effects of 2,3-dimercaptopropane-1-sulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the organotoxicity of dibutyltin dichloride (DBTC) in rats.
Merkord J; Weber H; Kröning G; Hennighausen G
Hum Exp Toxicol; 2000 Feb; 19(2):132-7. PubMed ID: 10773844
[TBL] [Abstract][Full Text] [Related]
45. Relative binding constants of arsenical-antidote adducts determined by NMR spectroscopy.
O'Connor RJ; McGown EL; Dill K; Hallowell SF
Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):365-8. PubMed ID: 2173085
[TBL] [Abstract][Full Text] [Related]
46. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
[TBL] [Abstract][Full Text] [Related]
47. Determination of arsenic metabolic complex excreted in human urine after administration of sodium 2,3-dimercapto-1-propane sulfonate.
Gong Z; Jiang G; Cullen WR; Aposhian HV; Le XC
Chem Res Toxicol; 2002 Oct; 15(10):1318-23. PubMed ID: 12387631
[TBL] [Abstract][Full Text] [Related]
48. Acute arsenic poisoning treated by intravenous dimercaptosuccinic acid (DMSA) and combined extrarenal epuration techniques.
Hantson P; Haufroid V; Buchet JP; Mahieu P
J Toxicol Clin Toxicol; 2003; 41(1):1-6. PubMed ID: 12645960
[TBL] [Abstract][Full Text] [Related]
49. Modeling the chelation of As(III) in lewisite by dithiols using density functional theory and solvent-assisted proton exchange.
Harper LK; Bayse CA
J Inorg Biochem; 2015 Dec; 153():60-67. PubMed ID: 26479948
[TBL] [Abstract][Full Text] [Related]
50. [Arsenic as an environmental problem].
Jensen K
Ugeskr Laeger; 2000 Dec; 162(49):6672-5. PubMed ID: 11188053
[TBL] [Abstract][Full Text] [Related]
51. Slow recovery from severe inorganic arsenic poisoning despite treatment with DMSA (2.3-dimercaptosuccinic acid).
Stenehjem AE; Vahter M; Nermell B; Aasen J; Lierhagen S; Mørland J; Jacobsen D
Clin Toxicol (Phila); 2007 May; 45(4):424-8. PubMed ID: 17486487
[TBL] [Abstract][Full Text] [Related]
52. Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats.
Flora SJ
Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):865-9. PubMed ID: 10561806
[TBL] [Abstract][Full Text] [Related]
53. Co-administration of monoisoamyl dimercaptosuccinic acid and Moringa oleifera seed powder protects arsenic-induced oxidative stress and metal distribution in mice.
Mishra D; Gupta R; Pant SC; Kushwah P; Satish HT; Flora SJ
Toxicol Mech Methods; 2009 Feb; 19(2):169-82. PubMed ID: 19778263
[TBL] [Abstract][Full Text] [Related]
54. Arsenic toxicology: five questions.
Aposhian HV; Aposhian MM
Chem Res Toxicol; 2006 Jan; 19(1):1-15. PubMed ID: 16411650
[No Abstract] [Full Text] [Related]
55. Pyruvate and lactate metabolism in livers of guinea pigs perfused with chelating agents after repeated treatment with As2O3.
Reichl FX; Kreppel H; Forth W
Arch Toxicol; 1991; 65(3):235-8. PubMed ID: 1647157
[TBL] [Abstract][Full Text] [Related]
56. Dimercaptan metal-binding agents influence the biotransformation of arsenite in the rabbit.
Maiorino RM; Aposhian HV
Toxicol Appl Pharmacol; 1985 Feb; 77(2):240-50. PubMed ID: 2983455
[TBL] [Abstract][Full Text] [Related]
57. Arsenic species excretion after dimercaptopropanesulfonic acid (DMPS) treatment of an acute arsenic trioxide poisoning.
Heinrich-Ramm R; Schaller H; Horn J; Angerer J
Arch Toxicol; 2003 Feb; 77(2):63-8. PubMed ID: 12590357
[TBL] [Abstract][Full Text] [Related]
58. 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid, and meso-2,3-dimercaptosuccinic acid inhibit delta-aminolevulinate dehydratase from human erythrocytes in vitro.
Nogueira CW; Santos FW; Soares FA; Rocha JB
Environ Res; 2004 Mar; 94(3):254-61. PubMed ID: 15016592
[TBL] [Abstract][Full Text] [Related]
59. Cryptic exposure to arsenic.
Rossy KM; Janusz CA; Schwartz RA
Indian J Dermatol Venereol Leprol; 2005; 71(4):230-5. PubMed ID: 16394429
[TBL] [Abstract][Full Text] [Related]
60. 2,3-Dithioerythritol, a possible new arsenic antidote.
Boyd VL; Harbell JW; O'Connor RJ; McGown EL
Chem Res Toxicol; 1989; 2(5):301-6. PubMed ID: 2562424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
